2025 Annual Meeting | PL6 - Frontiers in Neuroscience Plenary Session

Date Wednesday 04/09/25

Time 09:15 AM - 11:30 AM PDT Add To Calendar

Location San Diego Convention Center | Ballroom 20

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Plenary Session

Director(s) Brent L. Fogel, MD, PhD, FAAN

Topic(s) General Neurology

Learning Objectives This session features basic and translational research related to clinical issues of importance. Six outstanding speakers will summarize their recent research finding and dive into the clinical implications of the results.

CME Available 2.25 CME credits

Program Tracks Brain Health

Program Materials

Event Timeline
09:15 AM - 09:35 AM PDT	Speaker	A Roadmap to Precision Medicine in Neurodegenerative Diseases Nilufer Taner, MD, PhD, FAAN
09:35 AM - 09:55 AM PDT	Speaker	Bioengineering Tools for Noninvasive Control and Monitoring of the Brain Jerzy Szablowski, PhD
09:55 AM - 10:15 AM PDT	Speaker	Impact of Climate Change on Global Brain Health Beth A. Malow, MD, MS, FAAN
10:15 AM - 10:35 AM PDT	Speaker	Precision Medicine in Neurology: Cutting Edge and Emerging Pharmacogenomics for Personalized Neurological Care William D. Freeman, MD, FAAN
10:35 AM - 10:55 AM PDT	Speaker	CAR-T Therapy Michel Sadelain, MD, PhD

Faculty Disclosures
Nilufer Taner, MD, PhD, FAAN	The institution of Dr. Taner has received research support from NIH.
Michel Sadelain, MD, PhD	No disclosure on file
Jerzy Szablowski, PhD	Dr. Szablowski has stock in Imprint Bio Inc. Dr. Szablowski has stock in Teladoc. Dr. Szablowski has stock in Moderna. Dr. Szablowski has stock in GSK. Dr. Szablowski has stock in Biontech. The institution of Dr. Szablowski has received research support from NIH. The institution of Dr. Szablowski has received research support from Packard Foundation. The institution of Dr. Szablowski has received research support from MJ Fox Foundation for Parkinson's Disease Research. The institution of Dr. Szablowski has received research support from The Harold G. and Leila Y. Mathers Foundation. The institution of Dr. Szablowski has received research support from The Welch Foundation. The institution of Dr. Szablowski has received research support from DARPA. The institution of Dr. Szablowski has received research support from ARIA. The institution of Dr. Szablowski has received research support from John S. Dunn Foundation. The institution of Dr. Szablowski has received research support from Brain and Behavior Research Foundation. Dr. Szablowski has received intellectual property interests from a discovery or technology relating to health care. Dr. Szablowski has received intellectual property interests from a discovery or technology relating to health care. Dr. Szablowski has received intellectual property interests from a discovery or technology relating to health care. Dr. Szablowski has received intellectual property interests from a discovery or technology relating to health care. Dr. Szablowski has received intellectual property interests from a discovery or technology relating to health care. Dr. Szablowski has received intellectual property interests from a discovery or technology relating to health care.
William D. Freeman, MD, FAAN	Dr. Freeman has nothing to disclose.
Beth A. Malow, MD, MS, FAAN	Dr. Malow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurim Pharmaceuticals. The institution of Dr. Malow has received research support from National Institutes of Health. The institution of Dr. Malow has received research support from Department of Defense. The institution of Dr. Malow has received research support from PCORI.
Tanja Jovanovic, PhD	No disclosure on file
Brent L. Fogel, MD, PhD, FAAN	Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Ataxia Foundation. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ataxia Global Initiative. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genes. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuromarkers. The institution of Dr. Fogel has received research support from the National Institutes of Health. The institution of Dr. Fogel has received research support from the National Ataxia Foundation. The institution of an immediate family member of Dr. Fogel has received research support from the National Institutes of Health, the National Science Foundation, and the Department of Defense. The institution of Dr. Fogel has received research support from US Department of Defense .

��ɫ��

��ɫ��